These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Dibromodulcitol-based combined postoperative chemotherapy of malignant astrocytomas and glioblastomas. Afra D; Kocsis B; Kerpel-Fronius S; Eckhardt S J Neurooncol; 1986; 4(1):65-70. PubMed ID: 3746387 [TBL] [Abstract][Full Text] [Related]
24. High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during (131)I-meta-iodobenzylguanidine treatment in children with neuroblastoma. van Santen HM; de Kraker J; van Eck BL; de Vijlder JJ; Vulsma T Cancer; 2002 Apr; 94(7):2081-9. PubMed ID: 11932913 [TBL] [Abstract][Full Text] [Related]
25. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: early results of a pilot study. Prados MD; Wara WM; Edwards MS; Cogen PH Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):431-8. PubMed ID: 8276658 [TBL] [Abstract][Full Text] [Related]
26. Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Childrens Cancer Group study. Evans AE; Anderson JR; Lefkowitz-Boudreaux IB; Finlay JL Med Pediatr Oncol; 1996 Jul; 27(1):8-14. PubMed ID: 8614396 [TBL] [Abstract][Full Text] [Related]
27. Growth impairment and growth hormone therapy in children treated for malignant brain tumours. Ilveskoski I; Saarinen UM; Wiklund T; Sipilä I; Mäkipernaa A; Perkkiö M; Lanning M; Salmi TT; Pihko H Eur J Pediatr; 1997 Oct; 156(10):764-9. PubMed ID: 9365064 [TBL] [Abstract][Full Text] [Related]
28. Thyroid diseases after treatment of Hodgkin's disease. Hancock SL; Cox RS; McDougall IR N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693 [TBL] [Abstract][Full Text] [Related]
29. Long-term effects of treatment on endocrine function in children with brain tumors. Duffner PK; Cohen ME; Anderson SW; Voorhess ML; MacGillivray MH; Panahon A; Brecher ML Ann Neurol; 1983 Nov; 14(5):528-32. PubMed ID: 6651240 [TBL] [Abstract][Full Text] [Related]
30. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. Sposto R; Ertel IJ; Jenkin RD; Boesel CP; Venes JL; Ortega JA; Evans AE; Wara W; Hammond D J Neurooncol; 1989 Jul; 7(2):165-77. PubMed ID: 2550594 [TBL] [Abstract][Full Text] [Related]
31. Aplastic anemia induced by cyclohexylchloroethylnitrousurea. Elis A; Lishner M; Savin H; Ravid M Anticancer Drugs; 1994 Feb; 5(1):105-7. PubMed ID: 8186424 [TBL] [Abstract][Full Text] [Related]
32. Restrictive lung disease following treatment for malignant brain tumors: a potential late effect of craniospinal irradiation. Jakacki RI; Schramm CM; Donahue BR; Haas F; Allen JC J Clin Oncol; 1995 Jun; 13(6):1478-85. PubMed ID: 7751895 [TBL] [Abstract][Full Text] [Related]
33. Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma. Pons MA; Finlay JL; Walker RW; Puccetti D; Packer RJ; McElwain M J Neurooncol; 1992 Oct; 14(2):151-8. PubMed ID: 1432038 [TBL] [Abstract][Full Text] [Related]
34. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma. Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391 [TBL] [Abstract][Full Text] [Related]
35. Pituitary hormone dysfunction after proton beam radiation therapy in children with brain tumors. Viswanathan V; Pradhan KR; Eugster EA Endocr Pract; 2011; 17(6):891-6. PubMed ID: 21613054 [TBL] [Abstract][Full Text] [Related]
36. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH). Gnekow AK; Kortmann RD; Pietsch T; Emser A Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548 [TBL] [Abstract][Full Text] [Related]
37. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients. Katsanis E; Shapiro RS; Robison LL; Haake RJ; Kim T; Pescovitz OH; Ramsay NK Bone Marrow Transplant; 1990 May; 5(5):335-40. PubMed ID: 2350628 [TBL] [Abstract][Full Text] [Related]
38. Endocrinological late effects following radiotherapy and chemotherapy of childhood brain tumours. Schmiegelow M Dan Med Bull; 2006 Aug; 53(3):326-41. PubMed ID: 17092452 [No Abstract] [Full Text] [Related]
39. Radiotherapy and combination chemotherapy with carmustine, vincristine, and procarbazine (BVP) in primary brain tumors. Comella G; Scoppa G; De Marco M; Ianniello GP; Melillo G; Coucourde F; Zarrilli D J Neurooncol; 1985; 3(1):13-7. PubMed ID: 2987423 [TBL] [Abstract][Full Text] [Related]
40. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. Prados MD; Seiferheld W; Sandler HM; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1147-52. PubMed ID: 15001257 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]